Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

GKB OPHTHALMICS LTD. - 533212 - Statement Of Deviation(S) Or Variation(S) Under Regulation 32 Of SEBI ( Listing Obligations And Disclosure Requirements ) Regulations , 2015

 Pursuant to Regulation 32 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 read with SEBI Circular No. CIR/CFD/CMD1/162/2019, dated December 24, 2019, we would like to inform you that the Audit Committee in their meeting held on November 12, 2022, has reviewed the utilisation of funds which were raised by means of preferential allotment and noted that there was no utilization of funds, during the quarter ended September 30, 2022.
12-11-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Outcome for Outcome Of Board Meeting Of GKB Ophthalmics Limited Held On November 12, 2022.

 The meeting of the Board of Directors of the Company was held on November 12, 2022, which considered and took on record the Unaudited Standalone and Consolidated Financial Results of the Company for the quarter and half year ended September 30, 2022. Pursuant to Regulation 33 (3)(d) of SEBI (Listing Obligations and Disclosure Requirements)Regulations, 2015, enclosed please find the following : 1. Standalone Financial Results for the quarter and half year ended September 30, 2022, together with the Limited Review Report. 2. Consolidated Financial Results for the quarter and half year ended September 30, 2022, along with Limited Review Report. The above Unaudited Financial Results and the Limited Review Reports are available on the Company''s website www.gkb.net and on the BSE website www.bseindia.com The Board of Directors'' Meeting started at 2:05 P.M and ended at 3:20 P.M., on the same day.
12-11-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Board Meeting Intimation for Considering And Taking On Record The Unaudited Financial Results Of The Company For The Quarter And Half Year Ended September 30, 2022.

 GKB OPHTHALMICS LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/11/2022 ,inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter and half year ended September 30, 2022. The Notice can be accessed at the Company''s website at www.gkb.net Further, notice is hereby given with reference to the above meeting of the Board of Directors, that the Trading Window for dealing with equity shares of the Company, by designated persons, under the SEBI (Prohibition of Insider Trading) Regulations, 2015, has been closed from October 01, 2022 till the completion of 48 hours after the declaration of the said financial results of the Company. The Trading Window shall now re-open on Tuesday, November 15, 2022. This communication has been sent to all the Directors and all the designated employees of the Company.
27-10-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Submission Of Minutes Of 40Th Annual General Meeting Of The Company Held On 29Th September, 2022.

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to enclose herewith a copy of the Minutes of the proceedings of the 40th Annual General Meeting of the Company, held on 29th September, 2022.
21-10-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Statement Of Investor Complaints For The Quarter Ended September 2022

 No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Pooja BicholkarDesignation :- Company Secretary and Compliance Officer
11-10-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

 Please find herewith Certificate under Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018, for the quarter ended September 30, 2022.
11-10-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 ( PIT Regulations, 2015), intimation be and is hereby given that KrishnaGopal Gupta & Sons (HUF) , has purchased 197 equity shares aggregating to Rs. 20308.17/- from 22.08.2022 to 20.09.2022, on market, which is not exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. However, as a good Corporate Governance measure, the disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from KrishnaGopal Gupta and Sons- HUF. Please acknowledge and take the same on record.
01-10-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - GKB Ophthalmics Limited - Scrutinizer''s Report :- Voting Results Of The AGM Held On September 29, 2022

 Pursuant to Regulation 44 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed the following :- 1. Consolidated Voting results pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, as Annexure I. 2. Scrutinizers' Report pursuant to Section 108 of the Companies Act, 2013, as Annexure II. All the resolutions were passed with requisite majority. Kindly take the same on record.
30-09-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Shareholder Meeting / Postal Ballot-Outcome of AGM

 The 40th Annual General Meeting of the Company was held at the Registered Office of the Company on Thursday, September 29, 2022, at 11.00 A.M., through Video Conference / Other Audio Visual Means. The meeting started at 11:00 A.M. and ended at 12:05 Noon. The proceedings of the AGM are enclosed herewith. Kindly take the same on record.
29-09-2022
Bigul

GKB OPHTHALMICS LTD. - 533212 - Announcement under Regulation 30 (LODR)-Code of Conduct under SEBI (PIT) Regulations, 2015

 Pursuant to provisions of Regulation 7(2) read with Regulation 6(2) of SEBI (Prohibition of Insider Trading) Regulations, 2015 (PIT Regulations, 2015), intimation be and is hereby given that Mrs. Usha Gupta belonging to promoter Group, has sold 102 equity shares on 23.09.2022, 9335 equity shares on 26.09.2022 and 18031 equity shares on 27.09.2022, aggregating to Rs. 2788045.11/-, on market, which is exceeding the threshold limit as prescribed under Regulation 7(2) of PIT Regulations, 2015. The disclosure required under Regulation 7(2) read with Regulation 6(2) of PIT Regulations, 2015, is enclosed herewith along with the copy of disclosure received from Mrs. Usha Gupta. Please acknowledge and take the same on record.
28-09-2022
Next Page
Close

Let's Open Free Demat Account